pravastatin has been researched along with Bilirubinemia in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akiyama, S; Ni'inuma, K; Nishigaki, R; Sugiyama, Y; Yamazaki, M | 1 |
| Hasegawa, Y; Ichikawa, T; Iwata, K; Kato, K; Sugiura, M; Tsuji, S; Yahara, T; Yamaguchi, J | 1 |
| Aiso, M; Akashi, M; Kurihara, H; Sano, N; Sasamoto, T; Tachizawa, H; Takada, Y; Takamori, Y; Takayanagi, M; Takikawa, H | 1 |
| Kakinuma, C; Kuwayama, C; Naba, H; Ogihara, T; Ohnishi, S | 1 |
| Kakinuma, C; Naba, H; Ogihara, T; Ohnishi, S | 1 |
| Horie, T; Nishikawa, K; Sano, N; Takikawa, H; Yamanaka, M | 1 |
| Kobayashi, K; Sugiyama, Y; Yamazaki, M | 2 |
8 other study(ies) available for pravastatin and Bilirubinemia
| Article | Year |
|---|---|
Biliary excretion of pravastatin in rats: contribution of the excretion pathway mediated by canalicular multispecific organic anion transporter.
Topics: Animals; Anion Transport Proteins; Bile; Bile Canaliculi; Carrier Proteins; Hyperbilirubinemia; Male; Pravastatin; Rats; Rats, Sprague-Dawley | 1997 |
Recommendation to Exclude Bile-Duct-Cannulated Rats with Hyperbilirubinemia for Proper Conduct of Biliary Drug Excretion Studies.
Topics: Animals; ATP-Binding Cassette Transporters; Bile; Bile Ducts; Bilirubin; Biomarkers; Catheterization; Hepatobiliary Elimination; Hyperbilirubinemia; Liver; Male; Models, Biological; Organic Anion Transporters; Pravastatin; Rats; Rats, Sprague-Dawley; Reproducibility of Results | 2016 |
Comparison of urinary excretion of pravastatin and temocapril in bile duct-ligated rats and Eisai hyperbilirubinemic rats (EHBR).
Topics: Animals; Bile Ducts; Cholestasis; Disease Models, Animal; Hyperbilirubinemia; Male; Pravastatin; Rats; Rats, Sprague-Dawley; Thiazepines | 2004 |
Eisai hyperbilirubinemic rat (EHBR) as an animal model affording high drug-exposure in toxicity studies on organic anions.
Topics: Animals; Anions; Area Under Curve; ATP-Binding Cassette Transporters; Blood Proteins; Creatine Kinase; Disease Models, Animal; Folic Acid Antagonists; Half-Life; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperbilirubinemia; Male; Methotrexate; Muscle, Skeletal; Pravastatin; Protein Binding; Rats; Rats, Inbred Strains; Toxicity Tests; Weight Gain | 2004 |
Improving effect of ethyl eicosapentanoate on statin-induced rhabdomyolysis in Eisai hyperbilirubinemic rats.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Eicosapentaenoic Acid; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperbilirubinemia; Muscle, Skeletal; Platelet Aggregation Inhibitors; Pravastatin; Rats; Rhabdomyolysis; Severity of Illness Index; Treatment Outcome | 2006 |
Mechanisms of biliary excretion of lithocholate-3-sulfate in Eisai hyperbilirubinemic rats (EHBR).
Topics: Animals; Bile; Colchicine; Hyperbilirubinemia; Indocyanine Green; Lithocholic Acid; Male; Pravastatin; Rats; Rats, Mutant Strains; Rats, Sprague-Dawley; Sulfobromophthalein; Taurocholic Acid | 1995 |
Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinemic rats.
Topics: Animals; Biliary Tract; Biological Transport, Active; Enzyme Inhibitors; Hyperbilirubinemia; Liver; Male; Pravastatin; Rats; Rats, Mutant Strains; Rats, Sprague-Dawley; Species Specificity | 1996 |
Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinaemic rats.
Topics: Adenosine Triphosphate; Animals; Biliary Tract; Biological Transport, Active; Enzyme Inhibitors; Hyperbilirubinemia; Liver; Male; Pravastatin; Rats; Rats, Mutant Strains; Rats, Sprague-Dawley; Species Specificity | 1996 |